Related Experiment Videos
[Non alcoholic steatohepatitis]
E Manero1, J A Findor, A Avagnina
1División de Gastroenterología, Hospital de Clínicas José de San Martín, Facultad de Medicina, Universidad de Buenos Aires.
Medicina
|January 1, 1994
Summary
Non-alcoholic steatohepatitis (NASH) is often oligosymptomatic and linked to obesity. This study highlights NASH
Area of Science:
- Hepatology
- Gastroenterology
- Pathology
Context:
- Non-alcoholic steatohepatitis (NASH) is a growing concern, often associated with metabolic syndrome.
- Patients frequently present with hepatomegaly and biochemical abnormalities.
- NASH can mimic alcoholic liver disease and is a potential cause of cryptogenic cirrhosis.
Purpose:
- To prospectively evaluate clinical, biochemical, and histological features of non-alcoholic steatohepatitis (NASH).
- To assess the prevalence of steatosis, inflammation, and fibrosis in NASH patients.
- To underscore the diagnostic challenges and clinical significance of NASH.
Summary:
- A prospective study of 21 NASH patients revealed common hepatomegaly (100%) and abnormal liver enzymes.
- Histological analysis showed significant steatosis (mean score 2.6), inflammation (1.5), and fibrosis (1.8).
- Mallory bodies were present in 52% of cases, and 4 patients developed cirrhosis.
Impact:
- NASH is frequently underdiagnosed and presents in various clinical settings, primarily obesity.
- Histological findings are indistinguishable from alcoholic steatohepatitis.
- Highlights the importance of considering NASH in cryptogenic cirrhosis cases.